Extina FDA Approval History
FDA Approved: Yes (First approved June 12, 2007)
Brand name: Extina
Generic name: ketoconazole
Dosage form: Foam
Company: Stiefel Laboratories, Inc.
Treatment for: Seborrheic Dermatitis
Extina Foam is a topical formulation of the antifungal ketoconazole in VersaFoam for the treatment of seborrheic dermatitis.
Development timeline for Extina
| Date | Article |
|---|---|
| Jun 13, 2007 | Approval FDA Approves Extina for the Treatment of Seborrheic Dermatitis |
| Nov 24, 2004 | Connetics Receives FDA Non-Approvable Letter for Extina |
| Apr 8, 2004 | Connetics' New Drug Application for Extina Has Been Accepted for Filing by the FDA |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
